The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
about
Nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementUpdate on Autoimmune HepatitisPersistent hypertransaminasemia in asymptomatic children: a stepwise approachNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingImmunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsPediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsNonalcoholic Fatty Liver Disease: Pathophysiology and Management.Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisCurrent status and agenda in the diagnosis of nonalcoholic steatohepatitis in JapanNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Non-alcoholic fatty liver disease: An expanded reviewVerification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver diseaseFat: a matter of disturbance for the immune system.Histopathology of nonalcoholic fatty liver disease.Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease: The diagnosis and management.Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review.Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better managementThe revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.Recent concepts in non-alcoholic fatty liver disease.Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Histological assessment of non-alcoholic fatty liver disease.Role of international criteria in the diagnosis of autoimmune hepatitis.Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.Nonalcoholic fatty liver disease - current status and future directions.Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.Practical management of the increasing burden of non-alcoholic fatty liver disease.Natural course of subjects with elevated liver tests and normal liver histology.Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
P2860
Q24555779-04A5F8D6-370D-4E88-9A3B-A8FFD8F783F3Q24649618-8A01537E-26CF-43DC-8D5F-1263B31A6648Q26781765-333D6F0F-61CD-45C3-8CDE-B9B5545A942EQ26829883-C786BA97-904A-428F-B72F-E3CDE73321ECQ27006131-6BCB8A75-9792-4312-964A-78436BF3F3AAQ28069584-8834A343-A7B8-4080-A306-F156C3653453Q28076505-7E3EEA1B-E53C-4B9E-82F0-BAA6B26FE158Q28079432-E20A773A-39CC-48C0-AAE7-C253C2322558Q30241387-1B73C8A9-7F12-4A50-AD9D-A5BB804543B7Q30368738-7F34F518-EF02-4266-8F3F-04BC7A3A4AC2Q30478139-870B2855-0A97-4987-BDC9-23B372C705B1Q33447479-4267773D-5703-4791-AEBE-3E6C2093C801Q33789868-EBBA4C82-FF2B-4208-8DBC-019A18810E31Q33795637-8A9B6901-CB52-486D-8679-E196AE898572Q34200814-B55BA5F9-3B66-441F-AA92-6F01B16A34FDQ34306736-45D9A070-2696-4821-9AC7-5B62A57202F7Q34636684-484B6C3D-524B-4194-90A2-EA04714CE024Q34758973-B2661981-49F7-486C-86F9-ED3763FBA6B4Q35543956-E832E27E-46B7-4E59-AC17-6F4575047213Q35559821-1EE2DE04-BB3E-4E10-BF07-03D188B06D8BQ35875273-73C4A3B6-291C-43E4-9E93-22EB68D2B116Q35914823-32C79429-DD5A-403C-A7C4-0DC1F138DB2BQ36234172-B7B77215-3C5E-4A4A-94F2-5E001AB76C53Q36260378-249C0AB9-0573-4184-8C2E-B631E59444BDQ36438251-1E350B64-D8AF-49EC-B2B4-6CC49959B02FQ36490242-A1746183-F00D-43AC-8F8D-99A69C21D7F1Q36634377-74338605-4FB2-42FB-8E7B-99D6C4B52758Q36950858-9624BF89-A18B-46E1-B92A-13F3CBE89340Q37066789-D4F8B24C-FFCF-4167-A22A-B71726059E78Q37473320-8409C008-7C01-4FEE-9FB2-61298C7525F1Q37976341-3CA5CD1A-C4E7-40D0-BF9C-8DAAB87DB214Q38128548-B2726AE7-B0AF-4750-AB82-2990531A418EQ38204970-A483D559-B194-4A63-9B5C-281B4FAC6D63Q38496935-49D8BCE7-6547-4795-8959-411A02C6EA4CQ38497449-658EF693-EF94-4711-8FC6-5A41F30E34F1Q38592767-A09439F8-2A9E-41F4-AAC1-1F18B2A36AC5Q39709297-7D77DA5F-9AB4-49D2-9DDE-B90A358A4DE4Q41059980-53D38B49-CEDF-4888-93C2-7771F2D13038Q41500162-CF5149A3-D0DB-48EE-BAC5-ECAD1BE738FDQ45006677-C8224350-2CC9-45A3-9A9C-12B7ABCDCED4
P2860
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@en
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@nl
type
label
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@en
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@nl
prefLabel
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@en
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@nl
P2093
P2860
P1476
The prevalence of autoantibodi ...... alcoholic Fatty liver disease.
@en
P2093
Keith D Lindor
Leon A Adams
Paul Angulo
P2860
P304
P356
10.1111/J.1572-0241.2004.30444.X
P407
P577
2004-07-01T00:00:00Z